# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-22-011510
Filing Date
2022-04-29
Accepted
2022-04-29 15:50:50
Documents
7
Period of Report
2022-04-29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | a2022proxystatement.htm | DEF 14A | 610571
2 | GRAPHIC | image.jpg | GRAPHIC | 83710
3 | GRAPHIC | image1.jpg | GRAPHIC | 139890
4 | GRAPHIC | image2.jpg | GRAPHIC | 132754
5 | GRAPHIC | image3.jpg | GRAPHIC | 3590
6 | GRAPHIC | image4a.jpg | GRAPHIC | 11689
7 | GRAPHIC | map2.jpg | GRAPHIC | 273856
| Complete submission text file | 0001628280-22-011510.txt |  | 1499404

Mailing Address 1668 S. GARFIELD AVENUE 2ND FLOOR ALHAMBRA CA 91801
Business Address 1668 S. GARFIELD AVENUE 2ND FLOOR ALHAMBRA CA 91801 (626) 282-0288
Apollo Medical Holdings, Inc. (Filer) CIK: 0001083446 (see all company filings)

EIN.: 870042699 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37392 | Film No.: 22874917
SIC: 8742 Services-Management Consulting Services